Impact of Hemodynamic Ramp Test-Guided HVAD RPM and Medication Adjustments on Exercise Tolerance and Quality of Life
NCT ID: NCT03021239
Last Updated: 2019-04-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2016-03-31
2019-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Home-Based Exercise Program Using Mobile Technology After Left Ventricular Assist Device Implantation
NCT06291922
Central and Cerebral Circulation in Early Stages After LVAD Implantation
NCT03087669
Investigation to Optimize Hemodynamic Management of Left Ventricular Assist Devices Using the CardioMEMS™
NCT03247829
LVAD Conditioning for Cardiac Recovery
NCT03238690
Cardiac Resynchronization Therapy (CRT) and Left Ventricular Assist Devices (LVAD) Therapy
NCT02083419
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The ramp testing may also be performed during a right heart catheterization procedure. In a catheterization procedure, a doctor inserts a thin, flexible tube (catheter) into a vein or artery in the upper leg (groin), arm or neck and guides it to the heart using X-ray imaging. Doctors normally perform this procedure to measure the pressure and blood flow in the heart (otherwise called hemodynamic measurements). If the ramp testing is performed during this procedure, then the doctors have additional measurements to consider before choosing a final speed for the Left Ventricular Assist Device (LVAD) pump and appropriate medical treatment.
All of the procedures in this study are considered standard of care. The research part is randomly assigning the subject to one of the two methods of testing in this study. Subjects have a 50/50 chance of being in either testing group.
Baseline Visit (1 - 3 months after Left Ventricular Assist Device (LVAD) implant)
The following will be performed:
* Subjects will be asked to sign this consent form.
* Physical exam with an assessment of heart failure symptoms, and medical history will be recorded
* Routine blood tests (about 1 tablespoon will be drawn)
* Subjects will be randomly assigned to one of the two testing groups. If there is time, the ramp test can be performed at this visit, but usually it will be scheduled to occur a different day in about 1 to 4 weeks.
* 6 Minute Walk Test. This test measures how far the subject can walk in 6 minutes. If needed, this can be completed the day of the ramp test.
* Subjects will be asked to complete a questionnaire about their current quality of life. This will take about 10 minutes. If needed, this can be completed the day of the ramp test.
Ramp Testing Groups:
1. Echo Guided Testing - This testing uses echocardiography to create images of the heart and make measurements while gradually increasing the heart pump speed. The final pump speed and medical treatment are determined using the echo measurements. This will take about 45 minutes.
OR
2. Hemodynamic-Echo Ramp Testing - This testing is performed during a right heart catheterization procedure which provides hemodynamic measurements (pressure and blood flow) in addition to the echocardiography measurements. With this method, more echo images and measurements are taken. The final pump speed and medical treatment adjustments are made using the hemodynamic measurements as well as the information from the echo. This test will take about 1 hour and 45 minutes.
6 Months after Baseline Visit
The following will be performed:
* Physical exam with an assessment of heart failure symptoms, and medical history will be recorded
* Routine blood tests (about 1 tablespoon will be drawn)
* 6 Minute Walk Test. This test measures how far the subject can walk in 6 minutes.
* Subjects will be asked to complete a questionnaire about their current quality of life. This will take about 10 minutes.
* All subjects will undergo a Hemodynamic-Echo Ramp Test at 6 months after the baseline visit.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1) Echo Guided Testing -
This testing uses echocardiography to create images of the heart and make measurements while gradually increasing the heart pump speed. The final pump speed and medical treatment are determined using the echo measurements. This will take about 45 minutes.
Hemodynamic-Echo Ramp Testing -
2) Hemodynamic-Echo Ramp Testing -
This testing is performed during a right heart catheterization procedure which provides hemodynamic measurements (pressure and blood flow) in addition to the echocardiography measurements. With this method, more echo images and measurements are taken. The final pump speed and medical treatment adjustments are made using the hemodynamic measurements as well as the information from the echo. This test will take about 1 hour and 45 minutes.
Echo Guided Testing
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Echo Guided Testing
Hemodynamic-Echo Ramp Testing -
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Newly implanted HVAD
3. HVAD support anticipated for at least 6 months
4. Patient is ambulatory and discharged from hospital without inotropes
5. Patient is between 1 and 3 months post implant
6. Patient has not had a right heart catheterization since discharged from HVAD implantation hospitalization
Exclusion Criteria
2. Patients currently has Right Ventricle (RV) failure requiring home inotropes
3. Inability to preformed right heart cath
4. Inadequate echocardiographic windows
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Chicago
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UC San Diego Medical Center
San Diego, California, United States
Stanford Medical Center
Stanford, California, United States
Northwestern University
Chicago, Illinois, United States
The University of Chicago
Chicago, Illinois, United States
Montefiore Medical Center
The Bronx, New York, United States
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
University of Washington School of Medicine
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Uriel N, Burkhoff D, Rich JD, Drakos SG, Teuteberg JJ, Imamura T, Rodgers D, Raikhelkar J, Vorovich EE, Selzman CH, Kim G, Sayer G. Impact of Hemodynamic Ramp Test-Guided HVAD Speed and Medication Adjustments on Clinical Outcomes. Circ Heart Fail. 2019 Apr;12(4):e006067. doi: 10.1161/CIRCHEARTFAILURE.119.006067.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB15-1733
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.